[go: up one dir, main page]

DE60223707D1 - Calcium-l-threonat zur behandlung von knochenfrakturen - Google Patents

Calcium-l-threonat zur behandlung von knochenfrakturen

Info

Publication number
DE60223707D1
DE60223707D1 DE60223707T DE60223707T DE60223707D1 DE 60223707 D1 DE60223707 D1 DE 60223707D1 DE 60223707 T DE60223707 T DE 60223707T DE 60223707 T DE60223707 T DE 60223707T DE 60223707 D1 DE60223707 D1 DE 60223707D1
Authority
DE
Germany
Prior art keywords
threonate
calcium
treatment
bone fractures
fractures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60223707T
Other languages
English (en)
Other versions
DE60223707T2 (de
Inventor
Kai Yu
Zhiwen Wang
Xiangguo Dai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Juneng Industry Co Ltd
Original Assignee
Juneng Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juneng Industry Co Ltd filed Critical Juneng Industry Co Ltd
Application granted granted Critical
Publication of DE60223707D1 publication Critical patent/DE60223707D1/de
Publication of DE60223707T2 publication Critical patent/DE60223707T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60223707T 2001-07-03 2002-07-02 Calcium-l-threonat zur behandlung von knochenfrakturen Expired - Fee Related DE60223707T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN01119870 2001-07-03
CNB011198702A CN1196480C (zh) 2001-07-03 2001-07-03 L－苏糖酸钙在制备预防或治疗骨折的药物中的用途
PCT/CN2002/000468 WO2003004011A1 (en) 2001-07-03 2002-07-02 Calcium l-threonate for preventing or treating bone facture

Publications (2)

Publication Number Publication Date
DE60223707D1 true DE60223707D1 (de) 2008-01-03
DE60223707T2 DE60223707T2 (de) 2008-10-30

Family

ID=4663771

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60223707T Expired - Fee Related DE60223707T2 (de) 2001-07-03 2002-07-02 Calcium-l-threonat zur behandlung von knochenfrakturen
DE02748548T Pending DE02748548T1 (de) 2001-07-03 2002-07-02 Calcium-l-threonat zur prävention oder behandlung von knochenfrakturen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE02748548T Pending DE02748548T1 (de) 2001-07-03 2002-07-02 Calcium-l-threonat zur prävention oder behandlung von knochenfrakturen

Country Status (8)

Country Link
US (1) US6727288B2 (de)
EP (1) EP1443918B1 (de)
JP (1) JP2005519856A (de)
KR (1) KR100737278B1 (de)
CN (1) CN1196480C (de)
CA (1) CA2471232A1 (de)
DE (2) DE60223707T2 (de)
WO (1) WO2003004011A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197561C (zh) * 2001-07-03 2005-04-20 北京巨能亚太生命科学研究中心 L－苏糖酸钙在制备预防或治疗损及软骨的疾病的药物中的用途
CN100367952C (zh) * 2003-09-30 2008-02-13 戴向国 一种含有l-苏糖酸钙和大豆异黄酮的组合物
US20050244499A1 (en) * 2004-05-03 2005-11-03 Robert Diaz Method and device for reducing susceptibility to fractures in long bones
US20050244451A1 (en) * 2004-05-03 2005-11-03 Robert Diaz Method and device for reducing susceptibility to fractures in vertebral bodies
KR20070039581A (ko) * 2004-08-05 2007-04-12 고도 슈세이 가부시키가이샤 칼슘 흡수 촉진 조성물
US20060089642A1 (en) * 2004-10-27 2006-04-27 Diaz Robert L Prefracture spinal implant for osteoporotic unfractured bone
US20060223730A1 (en) * 2005-04-04 2006-10-05 Hl Distribution Company Calcium supplements
US20080249178A1 (en) 2007-03-22 2008-10-09 Guosong Liu Magnesium compositions and uses thereof for increasing lifespan
US8377473B2 (en) * 2009-07-01 2013-02-19 Magceutics, Inc. Slow release magnesium composition and uses thereof
RU2548776C2 (ru) * 2013-01-11 2015-04-20 Общество С Ограниченной Ответственностью "Парафарм" Способ и препарат для ускорения консолидации переломов костей
US11022600B2 (en) * 2014-05-01 2021-06-01 Shimadzu Corporation Method for assessing state of differentiation of cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07126181A (ja) * 1993-11-05 1995-05-16 Hoechst Japan Ltd 骨折の予防および治療剤
US5656598A (en) * 1994-03-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Use of fibroblast growth factors to stimulate bone growth
WO1996025165A1 (en) * 1995-02-17 1996-08-22 Merck & Co., Inc. Method of lessening the risk of non-vertebral bone fractures
CN1039571C (zh) * 1996-06-13 1998-08-26 北京巨能经贸发展有限责任公司 L-苏糖酸钙的用途
CN1053653C (zh) * 1997-08-29 2000-06-21 北京巨能亚太生命科学研究中心 新l－苏糖酸衍生物
CN1215592A (zh) * 1997-10-28 1999-05-05 马斐文 L－苏糖酸钙口服液
CN1148175C (zh) * 1998-07-08 2004-05-05 北京巨能亚太生命科学研究中心 L-苏糖酸钙预防、抑制和治疗骨质疏松和佝偻病的用途
CN1074762C (zh) * 1998-08-18 2001-11-14 北京巨能亚太生命科学研究中心 L－苏糖酸铬盐、其制备方法及其应用
CN1133379C (zh) * 2001-02-20 2004-01-07 北京巨能亚太生命科学研究中心 一种等渗运动饮料及其制备方法

Also Published As

Publication number Publication date
EP1443918A1 (de) 2004-08-11
EP1443918B1 (de) 2007-11-21
WO2003004011A1 (en) 2003-01-16
DE60223707T2 (de) 2008-10-30
KR100737278B1 (ko) 2007-07-09
CN1328820A (zh) 2002-01-02
EP1443918A4 (de) 2004-11-24
DE02748548T1 (de) 2004-11-11
JP2005519856A (ja) 2005-07-07
CN1196480C (zh) 2005-04-13
KR20040011541A (ko) 2004-02-05
CA2471232A1 (en) 2003-01-16
US6727288B2 (en) 2004-04-27
US20020169210A1 (en) 2002-11-14
HK1063603A1 (en) 2005-01-07

Similar Documents

Publication Publication Date Title
DE50312145D1 (de) Vorrichtung zur behandlung von frakturen des femur
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
DE60214477D1 (de) Implantat zur Regeneration von Knorpelgewebe
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE362344T1 (de) Vorrichtung zur drehstabilisierung von knochensegmenten
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE451921T1 (de) Phenylindole zur behandlung von hiv
ATE376444T1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
FIU20060389U0 (fi) Luusairauksien hoito
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE414512T1 (de) Kombinationstherapie zur behandlung von krebs
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE60203207D1 (de) Zange zur orthodontischen Behandlung
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60223707D1 (de) Calcium-l-threonat zur behandlung von knochenfrakturen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee